185 related articles for article (PubMed ID: 12960028)
1. Metabolic, endocrine, and immune effects of stress hyperglycemia in a rabbit model of prolonged critical illness.
Weekers F; Giulietti AP; Michalaki M; Coopmans W; Van Herck E; Mathieu C; Van den Berghe G
Endocrinology; 2003 Dec; 144(12):5329-38. PubMed ID: 12960028
[TBL] [Abstract][Full Text] [Related]
2. Endocrine and metabolic effects of growth hormone (GH) compared with GH-releasing peptide, thyrotropin-releasing hormone, and insulin infusion in a rabbit model of prolonged critical illness.
Weekers F; Michalaki M; Coopmans W; Van Herck E; Veldhuis JD; Darras VM; Van den Berghe G
Endocrinology; 2004 Jan; 145(1):205-13. PubMed ID: 14551231
[TBL] [Abstract][Full Text] [Related]
3. Increasing intravenous glucose load in the presence of normoglycemia: effect on outcome and metabolism in critically ill rabbits.
Derde S; Vanhorebeek I; Ververs EJ; Vanhees I; Darras VM; Van Herck E; Larsson L; Van den Berghe G
Crit Care Med; 2010 Feb; 38(2):602-11. PubMed ID: 19851097
[TBL] [Abstract][Full Text] [Related]
4. A novel in vivo rabbit model of hypercatabolic critical illness reveals a biphasic neuroendocrine stress response.
Weekers F; Van Herck E; Coopmans W; Michalaki M; Bowers CY; Veldhuis JD; Van den Berghe G
Endocrinology; 2002 Mar; 143(3):764-74. PubMed ID: 11861495
[TBL] [Abstract][Full Text] [Related]
5. Tissue-specific glucose toxicity induces mitochondrial damage in a burn injury model of critical illness.
Vanhorebeek I; Ellger B; De Vos R; Boussemaere M; Debaveye Y; Perre SV; Rabbani N; Thornalley PJ; Van den Berghe G
Crit Care Med; 2009 Apr; 37(4):1355-64. PubMed ID: 19242345
[TBL] [Abstract][Full Text] [Related]
6. The manner of the inflammation-boosting effect caused by acute hyperglycemia secondary to overfeeding and the effects of insulin therapy in a rat model of sepsis.
Yoneyama S; Terashima H; Yamaguchi R; Tadano S; Ohkohchi N
J Surg Res; 2013 Nov; 185(1):380-7. PubMed ID: 23932353
[TBL] [Abstract][Full Text] [Related]
7. Clinical potential of insulin therapy in critically ill patients.
Mesotten D; Van den Berghe G
Drugs; 2003; 63(7):625-36. PubMed ID: 12656643
[TBL] [Abstract][Full Text] [Related]
8. Moderate glycemic control safe in critically ill adult burn patients: A 15 year cohort study.
Stoecklin P; Delodder F; Pantet O; Berger MM
Burns; 2016 Feb; 42(1):63-70. PubMed ID: 26691869
[TBL] [Abstract][Full Text] [Related]
9. Impact of hyperglycemia on neuropathological alterations during critical illness.
Sonneville R; den Hertog HM; Güiza F; Gunst J; Derese I; Wouters PJ; Brouland JP; Polito A; Gray F; Chrétien F; Charlier P; Annane D; Sharshar T; Van den Berghe G; Vanhorebeek I
J Clin Endocrinol Metab; 2012 Jun; 97(6):2113-23. PubMed ID: 22442271
[TBL] [Abstract][Full Text] [Related]
10. Optimal insulin treatment in syngeneic islet transplantation.
Merino JF; Nacher V; Raurell M; Biarnés M; Soler J; Montanya E
Cell Transplant; 2000; 9(1):11-8. PubMed ID: 10784061
[TBL] [Abstract][Full Text] [Related]
11. Glucose homeostasis, nutrition and infections during critical illness.
Ingels C; Vanhorebeek I; Van den Berghe G
Clin Microbiol Infect; 2018 Jan; 24(1):10-15. PubMed ID: 28082192
[TBL] [Abstract][Full Text] [Related]
12. Increasing glucose load while maintaining normoglycemia does not evoke neuronal damage in prolonged critically ill rabbits.
Sonneville R; den Hertog HM; Derde S; Güiza F; Derese I; Van den Berghe G; Vanhorebeek I
Clin Nutr; 2013 Dec; 32(6):1077-80. PubMed ID: 23352270
[TBL] [Abstract][Full Text] [Related]
13. Beta-blockade, but not normoglycemia or hyperinsulinemia, markedly diminishes stress-induced hyperglycemia in diabetic dogs.
Rashid S; Shi ZQ; Niwa M; Mathoo JM; Vandelangeryt ML; Bilinski D; Lewis GF; Vranic M
Diabetes; 2000 Feb; 49(2):253-62. PubMed ID: 10868942
[TBL] [Abstract][Full Text] [Related]
14. Reduction of oxidative stress by a new low-molecular-weight antioxidant improves metabolic alterations in a nonobese mouse diabetes model.
Novelli M; D'Aleo V; Lupi R; Paolini M; Soleti A; Marchetti P; Masiello P
Pancreas; 2007 Nov; 35(4):e10-7. PubMed ID: 18090226
[TBL] [Abstract][Full Text] [Related]
15. Survival benefits of intensive insulin therapy in critical illness: impact of maintaining normoglycemia versus glycemia-independent actions of insulin.
Ellger B; Debaveye Y; Vanhorebeek I; Langouche L; Giulietti A; Van Etten E; Herijgers P; Mathieu C; Van den Berghe G
Diabetes; 2006 Apr; 55(4):1096-105. PubMed ID: 16567534
[TBL] [Abstract][Full Text] [Related]
16. Insulin resistance and hyperglycemia in critical illness: role of insulin in glycemic control.
Robinson LE; van Soeren MH
AACN Clin Issues; 2004; 15(1):45-62. PubMed ID: 14767364
[TBL] [Abstract][Full Text] [Related]
17. Effects of two oral antidiabetics, pioglitazone and repaglinide, on aconitase inactivation, inflammation and oxidative/nitrosative stress in tissues under alloxan-induced hyperglycemia.
Gumieniczek A; Komsta L; Chehab MR
Eur J Pharmacol; 2011 May; 659(1):89-93. PubMed ID: 21237149
[TBL] [Abstract][Full Text] [Related]
18. Improved safety with intravenous insulin therapy for critically ill patients with renal failure.
Dickerson RN; Lynch AM; Maish GO; Croce MA; Minard G; Brown RO
Nutrition; 2014 May; 30(5):557-62. PubMed ID: 24296035
[TBL] [Abstract][Full Text] [Related]
19. Insulin therapy for the critically ill patient.
Van den Berghe G
Clin Cornerstone; 2003; 5(2):56-63. PubMed ID: 12800480
[TBL] [Abstract][Full Text] [Related]
20. Resveratrol shows vasoprotective effect reducing oxidative stress without affecting metabolic disturbances in insulin-dependent diabetes of rabbits.
Akar F; Pektas MB; Tufan C; Soylemez S; Sepici A; Ulus AT; Gokalp B; Ozturk K; Surucu HS
Cardiovasc Drugs Ther; 2011 Apr; 25(2):119-31. PubMed ID: 20676927
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
